HPLC investigation of free and bound propofol in human plasma and cerebrospinal fluid

The paper compares the total propofol concentration in the cerebrospinal fluid (CSF) with the free drug concentration in plasma measured in 35 humans scheduled for elective neurosurgical procedures during propofol anaesthesia. The concentrations of total and free propofol in the blood and CSF samples were measured by means of HPLC using liquid-liquid extraction and ultrafiltration in the sample preparation procedure. The arterial blood and CSF samples (collected from intraventricular drainage) were taken at the same time. According to the obtained results, the usually expected equality between free drug concentration in plasma and its total concentration in CSF is not valid for propofol: the unbound propofol concentration in plasma is not equal to its total concentration in CSF (p < 0.05). This difference suggests a substantial contribution of active transport in propofol transfer from blood into CSF. Moreover, the paper shows the presence of bound propofol in CSF, which is a novel finding.     

Quantitation of Propofol Metabolite, 2,6-Diisopropyl-1,4-quinol,by Gas Chromatography-Mass Spectrometry

Abstract

Propofol is an intravenous anaesthetic widely used for induction and maintenance of anaesthesia and for sedation. A sensitive and simple gas chromatography-mass spectrometry (GC-MS) method for the determination of 2,6-diisopropyl-1,4-quinol, the major hydroxylated propofol metabolite, is presented. Thymol was used as internal standard. Thymol and 2,6-diisopropyl-1,4-quinol are extracted under basic conditions. The extraction efficiencies for quinol metabolite was > 90 %. Standard curves were linear over the ranges of 50 to 2500 ng ml^?1. This assay represents an alternative to existing methods of 2,6-diisopropyl-1,4-quinol analysis, which use HPLC. The assay was applied to the analysis of propofol metabolism in vitro by rat liver microsomes.     

微乳液相色谱法测定人血浆中丙泊酚浓度

建立了基于微乳液相色谱(MELC)的人血浆中丙泊酚浓度的测定方法。采用Hypersil BDS C18色谱柱分离,并考察了微乳流动相中各组分对溶质洗脱的影响。优化的色谱条件: 以0.5%醋酸（含有3.0%十二烷基硫酸钠（SDS）,0.8%正庚烷,6.0%正丁醇）微乳为流动相,流速为1.0 mL/min,荧光检测器激发波长(λex)为274 nm、发射波长(λem)为312 nm,柱温为室温。人血浆样品用流动相稀释并离心后,直接进样分析。丙泊酚在0.25～10 μg/mL质量浓度范围内呈良好的线性关系,方法的回收率为(98.2±1.9)%～(104.6±2.2)%;日内测定峰面积的相对标准偏差(RSD)为1.42%～2.43%,日间测定峰面积的RSD为2.75%～4.79%。该方法简便可行、重复性好,可用于人血浆中丙泊酚浓度的测定。     

Development of a highly sensitive gas chromatography–mass spectrometry method preceded by solid‐phase microextraction for the analysis of propofol in low‐volume cerebral microdialysate samples

To date, the commonly used intravenous anesthetic propofol has been widely studied, and fundamental pharmacodynamic and pharmacokinetic characteristics of the drug are known. However, propofol has not yet been quantified in vivo in the target organ, the human brain. Here, cerebral microdialysis offers the unique opportunity to sample propofol in the living human organism. Therefore, a highly sensitive analytical method for propofol quantitation in small sample volumes of 30 μL, based on direct immersion solid‐phase microextraction was developed. Preconcentration was followed by gas chromatographic separation and mass spectrometric detection of the compound. This optimized method provided a linear range between the lower limit of detection (50 ng/L) and 200 μg/L. Matrix‐matched calibration was used to compensate recovery issues. A precision of 2.7% relative standard deviation between five consecutive measurements and an interday precision of 6.4% relative standard deviation could be achieved. Furthermore, the permeability of propofol through a cerebral microdialysate system was tested. In summary, the developed method to analyze cerebral microdialysate samples, allows the in vivo quantitation of propofol in the living human brain. Additionally the calculation of extracellular fluid levels is enabled since the recovery of the cerebral microdialysis regarding propofol was determined.     

Simultaneous quantification of propofol,ketamine and rocuronium in just 10 μL plasma using liquid chromatography coupled with quadrupole mass spectrometry and its pilot application to a pharmacokinetic study in rats

The combination of propofol, ketamine and rocuronium can be used for anesthesia of ventilated rats. However, reliable pharmacokinetic models of these drugs have yet to be developed in rats, and consequently optimal infusion strategies are also unknown. Development of pharmacokinetic models requires repeated measurements of drug concentrations. In small animals, samples must be tiny to avoid excessing blood extraction. We therefore developed a drug assay system using high‐performance liquid chromatography coupled with quadrupole mass spectrometry that simultaneously determines the concentration of all three drugs in just 10 μL rat plasma. We established a plasma extraction protocol, using acetonitrile as the precipitating reagent. Calibration curves were linear with R² = 0.99 for each drug. Mean recovery from plasma was 91–93% for propofol, 89–93% for ketamine and 90–92% for rocuronium. The assay proved to be accurate for propofol 4.1–8.3%, ketamine 1.9–7.8% and rocuronium ?3.6–4.7% relative error. The assay was also precise; the intra‐day precisions were propofol 2.0–4.0%, ketamine 2.7–2.9% and rocuronium 2.9–3.3% relative standard deviation. Finally, the method was successfully applied to measurement the three drugs in rat plasma samples. Mean plasma concentrations with standard deviations were propofol 2.0 μg/mL ±0.5%, ketamine 3.9 μg/mL ±1.0% and rocuronium 3.2 μg/mL ±0.8% during ventilation.     

Simultaneous determination of propofol and remifentanil in rat plasma by liquid chromatography–tandem mass spectrometry: application to preclinical pharmacokinetic drug–drug interaction analysis

Propofol (Pro) is an ultra‐short‐acting hypnotic agent used for general anesthesia that has no analgesic properties. Remifentanil (Rem) is an ultra‐short‐acting opioid administered concomitantly as an analgesic with Pro. To evaluate the pharmacokinetic interactions between Pro and Rem, we developed and validated a method combining high‐performance liquid chromatography with tandem mass spectrometry for simultaneous determination of Pro and Rem. The proposed method was successfully used to study the pharmacokinetic interactions of Pro and Rem coadministered to rats. Copyright © 2014 John Wiley & Sons, Ltd.     

丙泊酚复合司可林在精神病患者无抽搐电休克的应用

目的对丙泊酚复合司可林在精神病患者无抽搐电休克中的应用效果进行分析和总结。方法随机选择江西省新余市第二医院于2014年7月—2016年7月收治的精神科患者140例,均采用无抽搐电休克治疗。所有患者均给予丙泊酚与司可林行麻醉,观察麻醉效果。结果血氧饱和度及血压在给药后、电刺激时及清醒后差异不显著,但电刺激时的心率明显快于给药前,而给药后及清醒后的心率与给药前相比,无显著差异。本组共11例发生不良反应,但程度较轻微,停药后可自行消失,未作特殊处理。结论在精神病患者无抽搐电休克治疗中应用丙泊酚与司可林,心率、血压及血氧饱和度的变化较小,有效性高、安全性好,值得推广。     

反相高效液相色谱法测定人血浆中异丙酚浓度

用柱前衍生化反相高效液相色谱法测定人血浆中异丙酚浓度,为临床药理学研究提供了依据。提取的异丙酚及内标麝香草酚同时以Ｇｉｂｂｓ试剂衍生化,衍生物经色谱柱分离和紫外检测,异丙酚在５０～１５００μｇ／Ｌ浓度范围内呈线性关系（ｒ＝０．９９９１）。方法平均变异系数为６．１％,最低检出浓度为２４．８μｇ／Ｌ,已满意地用于临床药理学研究。